Outcomes of Elective and Non-elective Fenestrated-branched Endovascular Aortic Repair for Treatment of Thoracoabdominal Aortic Aneurysms

医学 四分位间距 择期手术 外科 危险系数 主动脉瘤 置信区间 入射(几何) 动脉瘤 内科学 光学 物理
作者
Marina Dias‐Neto,Andrea Vacirca,Ying Huang,Aidin Baghbani‐Oskouei,Tomasz Jakimowicz,Bernardo C. Mendes,Tilo Kölbel,Jonathan Sobocinski,L. Bertoglio,Barend Mees,Mauro Gargiulo,Nuno Dias,Andres Schanzer,Warren J. Gasper,Adam W. Beck,Mark A. Farber,Kevin Mani,Carlos H. Timaran,Darren B. Schneider,Luís Mendes Pedro,Nikolaos Tsilimparis,Stéphan Haulon,Matthew P. Sweet,E. Ferreira,Matthew J. Eagleton,Kak Khee Yeung,Manar Khashram,Katarzyna Jama,Giuseppe Panuccio,Fiona Rohlffs,Thomas Mesnard,R. Chiesa,Andrea Kahlberg,Geert Willem H. Schurink,Charlotte C. Lemmens,E. Gallitto,G. Faggioli,Angelos Karelis,E Parodi,Vivian Carla Gomes,A. Wanhainen,Mohammad Ahsan Habib,Jesus Porras Colon,Felipe Pavarino,Mirza S. Baig,R. E. C. Gouveia E Melo,Sean A. Crawford,Sara L. Zettervall,Rita Garcia,Tiago Ribeiro,Gonçalo Alves,Frederico Bastos Gonçalves,Kaj O. Kappe,Samira Elize Mariko van Knippenberg,B. L. Tran,Sinead Gormley,Gustavo S. Oderich
出处
期刊:Annals of Surgery [Lippincott Williams & Wilkins]
卷期号:278 (4): 568-577 被引量:10
标识
DOI:10.1097/sla.0000000000005986
摘要

To describe outcomes after elective and non-elective fenestrated-branched endovascular aortic repair (FB-EVAR) for thoracoabdominal aortic aneurysms (TAAAs).FB-EVAR has been increasingly utilized to treat TAAAs; however, outcomes after non-elective versus elective repair are not well described.Clinical data of consecutive patients undergoing FB-EVAR for TAAAs at 24 centers (2006-2021) were reviewed. Endpoints including early mortality and major adverse events (MAEs), all-cause mortality, and aortic-related mortality (ARM), were analyzed and compared in patients who had non-elective versus elective repair.A total of 2603 patients (69% males; mean age 72±10 year old) underwent FB-EVAR for TAAAs. Elective repair was performed in 2187 patients (84%) and non-elective repair in 416 patients [16%; 268 (64%) symptomatic, 148 (36%) ruptured]. Non-elective FB-EVAR was associated with higher early mortality (17% vs 5%, P <0.001) and rates of MAEs (34% vs 20%, P <0.001). Median follow-up was 15 months (interquartile range, 7-37 months). Survival and cumulative incidence of ARM at 3 years were both lower for non-elective versus elective patients (50±4% vs 70±1% and 21±3% vs 7±1%, P <0.001). On multivariable analysis, non-elective repair was associated with increased risk of all-cause mortality (hazard ratio, 1.92; 95% CI] 1.50-2.44; P <0.001) and ARM (hazard ratio, 2.43; 95% CI, 1.63-3.62; P <0.001).Non-elective FB-EVAR of symptomatic or ruptured TAAAs is feasible, but carries higher incidence of early MAEs and increased all-cause mortality and ARM than elective repair. Long-term follow-up is warranted to justify the treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
4u发布了新的文献求助10
1秒前
Lucia完成签到,获得积分10
1秒前
祝睿彦完成签到,获得积分10
1秒前
大个应助欢喜的小熊猫采纳,获得10
1秒前
2秒前
传奇3应助花生了什么树采纳,获得10
3秒前
4秒前
精明冥完成签到,获得积分10
4秒前
6秒前
科研通AI2S应助xiaochi采纳,获得10
6秒前
li发布了新的文献求助10
7秒前
超级盼海完成签到,获得积分10
7秒前
8秒前
9秒前
moon关注了科研通微信公众号
9秒前
懵懂的缘分应助Hanna采纳,获得10
10秒前
蔚蓝发布了新的文献求助10
10秒前
10秒前
刘亚军完成签到 ,获得积分10
11秒前
xiao发布了新的文献求助20
11秒前
魔幻慕梅发布了新的文献求助10
12秒前
12秒前
HaoHao04发布了新的文献求助10
14秒前
科目三应助科研通管家采纳,获得10
15秒前
丘比特应助科研通管家采纳,获得30
15秒前
无极微光应助科研通管家采纳,获得20
15秒前
16秒前
朴素大侠完成签到,获得积分20
16秒前
科研通AI2S应助科研通管家采纳,获得10
16秒前
16秒前
16秒前
花花123发布了新的文献求助10
17秒前
17秒前
17秒前
关耳发布了新的文献求助10
17秒前
19秒前
顺利的冰之完成签到,获得积分20
19秒前
黄佳慧完成签到 ,获得积分20
19秒前
感动手机完成签到 ,获得积分10
20秒前
鲜于灵竹完成签到,获得积分10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
Electrode Potentials 550
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6963185
求助须知:如何正确求助?哪些是违规求助? 8645302
关于积分的说明 18335569
捐赠科研通 6413265
什么是DOI,文献DOI怎么找? 3086677
关于科研通互助平台的介绍 2135900
邀请新用户注册赠送积分活动 2063130